Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

NCT02089217

Conditions
Arterial Occlusive Diseases, Brain Diseases, Cardiovascular Diseases, +12 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Huntsville Hospital/ Heart Center Research Alabama Huntsville, Alabama, United States
  • Banner University Medical Center Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center/Barrow Neurological Institute Phoenix, Arizona, United States
View all 167 locations
View Trial Details
Completed

GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)

NCT05109793

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Hospital Pequeno Principe Curitiba, Brazil
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
View all 13 locations
View Trial Details
Completed

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

NCT04845958

Conditions
Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +25 more
Locations
  • Investigational Site Number 2500036 Amiens, France
  • Investigational Site Number 2500014 Angers, France
  • Investigational Site Number 2500034 Argenteuil, France
  • Investigational Site Number 2500039 Bayonne, France
View all 40 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

NCT04669041

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number :1560033 Baotou, China
  • Investigational Site Number :1560001 Beijing, China
  • Investigational Site Number :1560068 Beijing, China
  • Investigational Site Number :1560021 Beijing, China
View all 40 locations
View Trial Details
Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. / Simon Williamson Clinic, PC Birmingham, Alabama, United States
  • The Center for Clinical Trials, Inc Saraland, Alabama, United States
View all 181 locations
View Trial Details

Related conditions